Ignite Creation Date:
2025-12-18 @ 9:15 AM
Ignite Modification Date:
2025-12-23 @ 9:19 PM
Study NCT ID:
NCT07059949
Status:
None
Last Update Posted:
2025-07-11 00:00:00
First Post:
2025-04-17 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-01-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-17 00:00:00
First Submit QC Date:
None
Study First Post Date:
2025-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-01 00:00:00
Last Update Post Date:
2025-07-11 00:00:00
Last Update Post Date Type:
ACTUAL